🔎 Trials Near Me

Utama › Sindrom Mielodisplastik › Ohio › Cleveland

Kajian klinikal Sindrom Mielodisplastik di Cleveland, OH

11 kajian untuk Sindrom Mielodisplastik sedang mencari peserta di lokasi dalam dan sekitar Cleveland (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Mengambil pesertaFasa 2
  • Case Western Reserve University, Cleveland
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Okt 2026 · NCT05564390

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

Mengambil pesertaFasa 1/2
  • Cleveland Clinic, Cleveland
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT05320198

A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

Mengambil pesertaFasa 3
  • Cleveland clinic OH, Cleveland
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Sep 2026 · NCT07422480

Co-Transplant of an Unmodified Haplo-Identical Graft With Cord Blood

Mengambil pesertaFasa 2
  • Case Comprehensive Cancer Center, University Hospitals Cleveland Medical Center Seidman Cancer Center, Cleveland
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Sep 2026 · NCT06904482

Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies

Mengambil pesertaFasa 1/2
  • Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Sep 2026 · NCT03471260

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

Mengambil pesertaFasa 3
  • Cleveland Clinic - Cleveland, Cleveland
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Ogo 2026 · NCT06499285

Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)

Mengambil pesertaFasa 1/2
  • Cleveland Clinic, Cleveland
Umur 18 ke atas · Semua jantina · Dikemas kini 10 Ogo 2026 · NCT05308264

5-Azacitidine and Decitabine Epigenetic Therapy for Myeloid Malignancies

Mengambil pesertaFasa awal 1
  • Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Mei 2026 · NCT04187703

Olutasidenib for the Treatment of Patients With IDH1 Mutated AML, MDS or CMML After Donor Hematopoietic Cell Transplant

Mengambil pesertaFasa 1
  • Cleveland Clinic Cancer Center, Cleveland
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Mac 2026 · NCT06543381

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Mengambil pesertaKajian pemerhatian
  • Massive Bio SYNERGY-AI site, Mayfield Heights · 12 mi jauh
Semua umur · Semua jantina · Dikemas kini 28 Okt 2025 · NCT03452774

Kajian Sindrom Mielodisplastik di bandar lain

Kajian lain di Cleveland

Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.